These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34794437)

  • 1. Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings.
    Sullivan MK; Jani BD; McConnachie A; Hanlon P; McLoone P; Nicholl BI; Carrero JJ; Nitsch D; McAllister D; Mair FS; Mark PB
    BMC Med; 2021 Nov; 19(1):278. PubMed ID: 34794437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies.
    Hanlon P; Jani BD; Nicholl B; Lewsey J; McAllister DA; Mair FS
    PLoS Med; 2022 Mar; 19(3):e1003931. PubMed ID: 35255092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimorbidity in a selected cohort compared to a representative sample: Does selection bias influence outcomes?
    Hanlon P; Bhautesh J; Mair F; McAllister D
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between risk, duration and cause of hospitalisations in people with rheumatoid arthritis and multimorbidity in the UK Biobank and Scottish Early Rheumatoid Arthritis (SERA) cohorts: Longitudinal observational study.
    Morton FR; Jani BD; Mair FS; McLoone P; Canning J; Macdonald S; McQueenie R; Siebert S; Nicholl BI
    Semin Arthritis Rheum; 2023 Feb; 58():152130. PubMed ID: 36459724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort.
    Jani BD; Hanlon P; Nicholl BI; McQueenie R; Gallacher KI; Lee D; Mair FS
    BMC Med; 2019 Apr; 17(1):74. PubMed ID: 30967141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort.
    Sullivan MK; Jani BD; Lees JS; Welsh CE; McConnachie A; Stanley B; Welsh P; Nicholl BI; Lyall DM; Carrero JJ; Nitsch D; Sattar N; Mair FS; Mark PB
    Clin Kidney J; 2021 Nov; 14(11):2409-2419. PubMed ID: 34754437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between multimorbidity and adverse clinical outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.
    Sullivan MK; Rankin AJ; Jani BD; Mair FS; Mark PB
    BMJ Open; 2020 Jun; 10(6):e038401. PubMed ID: 32606067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimorbidity prevalence and patterns in chronic kidney disease: findings from an observational multicentre UK cohort study.
    Hawthorne G; Lightfoot CJ; Smith AC; Khunti K; Wilkinson TJ
    Int Urol Nephrol; 2023 Aug; 55(8):2047-2057. PubMed ID: 36806100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.
    McQueenie R; Foster HME; Jani BD; Katikireddi SV; Sattar N; Pell JP; Ho FK; Niedzwiedz CL; Hastie CE; Anderson J; Mark PB; Sullivan M; O'Donnell CA; Mair FS; Nicholl BI
    PLoS One; 2020; 15(8):e0238091. PubMed ID: 32817712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between multimorbidity status and incident dementia: a prospective cohort study of 245,483 participants.
    Hu HY; Zhang YR; Aerqin Q; Ou YN; Wang ZT; Cheng W; Feng JF; Tan L; Yu JT
    Transl Psychiatry; 2022 Dec; 12(1):505. PubMed ID: 36476644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of latent class analysis-derived multimorbidity clusters with adverse health outcomes in patients with multiple long-term conditions: comparative results across three UK cohorts.
    Krauth SJ; Steell L; Ahmed S; McIntosh E; Dibben GO; Hanlon P; Lewsey J; Nicholl BI; McAllister DA; Smith SM; Evans R; Ahmed Z; Dean S; Greaves C; Barber S; Doherty P; Gardiner N; Ibbotson T; Jolly K; Ormandy P; Simpson SA; Taylor RS; Singh SJ; Mair FS; Jani BD;
    EClinicalMedicine; 2024 Aug; 74():102703. PubMed ID: 39045545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of chronic pain in LTCs and multimorbidity: A cross-sectional study using UK Biobank.
    McQueenie R; Jani BD; Siebert S; McLoone P; McCowan C; Macdonald S; Mair FS; Nicholl BI
    J Multimorb Comorb; 2021; 11():26335565211005870. PubMed ID: 35004337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function.
    Sullivan MK; Carrero JJ; Jani BD; Anderson C; McConnachie A; Hanlon P; Nitsch D; McAllister DA; Mair FS; Mark PB; Gasparini A
    BMC Med; 2022 Nov; 20(1):420. PubMed ID: 36320059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of multimorbidity of non-communicable diseases with mortality: a 10-year prospective study of 0.5 million Chinese adults.
    Zou S; Wang Z; Bhura M; Tang K
    Public Health; 2022 Apr; 205():63-71. PubMed ID: 35240390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of multimorbidity and their effects on adverse outcomes in rheumatoid arthritis: a study of 5658 UK Biobank participants.
    McQueenie R; Nicholl BI; Jani BD; Canning J; Macdonald S; McCowan C; Neary J; Browne S; Mair FS; Siebert S
    BMJ Open; 2020 Nov; 10(11):e038829. PubMed ID: 33234629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term conditions, multimorbidity and colorectal cancer risk in the UK Biobank cohort.
    Corcoran NM; Mair FS; Nicholl B; Macdonald S; Jani BD
    J Multimorb Comorb; 2022; 12():26335565221110123. PubMed ID: 36132374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants.
    Dodds RM; Granic A; Robinson SM; Sayer AA
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):62-68. PubMed ID: 31886632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort.
    Jani BD; Nicholl BI; McQueenie R; Connelly DT; Hanlon P; Gallacher KI; Lee D; Mair FS
    Europace; 2018 Nov; 20(FI_3):f329-f336. PubMed ID: 29112751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for the progression to multimorbidity among UK urban working-age adults. A community cohort study.
    Stagg AL; Harber-Aschan L; Hatch SL; Fear NT; Dorrington S; Madan I; Stevelink SAM
    PLoS One; 2023; 18(9):e0291295. PubMed ID: 37682940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inequalities in developing multimorbidity over time: A population-based cohort study from an urban, multi-ethnic borough in the United Kingdom.
    Bisquera A; Turner EB; Ledwaba-Chapman L; Dunbar-Rees R; Hafezparast N; Gulliford M; Durbaba S; Soley-Bori M; Fox-Rushby J; Dodhia H; Ashworth M; Wang Y
    Lancet Reg Health Eur; 2022 Jan; 12():100247. PubMed ID: 34901910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.